Does Lion’s Mane Help with Anxiety and Depression? A Review of the Clinical Evidence

12 hours ago
5 min read

Two randomized controlled trials have found that Hericium erinaceus supplementation significantly reduces anxiety and depression scores compared to placebo. The proposed mechanism is biological rather than behavioral: lion's mane supports the neurotrophin signaling pathways — NGF and BDNF — that antidepressant medications target pharmacologically, while simultaneously reducing neuroinflammation, a process now recognized as a core driver of mood disorders. The clinical evidence, while preliminary in scale, is mechanistically coherent and consistent across distinct study populations.

The neuroscience of anxiety and depression

Anxiety and depression are not single diseases with single causes. They are heterogeneous conditions with multiple overlapping biological drivers. Among the most consistently implicated are neurotrophin deficiency and chronic neuroinflammation — two processes that compromise the health and connectivity of neurons in circuits governing mood, stress response, and emotional regulation.

Brain-Derived Neurotrophic Factor (BDNF) is the neurotrophin most directly linked to mood disorders. Low BDNF levels are found consistently in patients with major depressive disorder, and the leading hypothesis for how antidepressant medications work — the neurotrophin hypothesis of depression — holds that their therapeutic effects depend on restoring BDNF signaling. SSRI antidepressants, exercise, and certain dietary interventions all elevate BDNF. So does lion's mane, through overlapping neurotrophin pathways that include both NGF and BDNF stimulation.

Neuroinflammation — low-grade chronic immune activation within the central nervous system — is the second major mechanism. Elevated pro-inflammatory cytokines, particularly TNF-α and IL-6, are found in a substantial subset of patients with depression and anxiety disorders. These inflammatory markers suppress neurotrophin production, impair synaptic function, and dysregulate the hypothalamic-pituitary-adrenal axis that governs stress response. Lion's mane contains polysaccharides and terpenoids that suppress the NF-κB pathway, reducing pro-inflammatory cytokine output — the same inflammatory machinery that underlies neuroinflammation-driven mood disorders.

The clinical evidence on lion's mane and mood

The foundational human study on lion's mane and mood was a randomized double-blind placebo-controlled trial published in Biomedical Research in 2010. Thirty women experiencing mood disturbances associated with menopause were randomly assigned to consume lion's mane-containing cookies or placebo cookies for four weeks. The treatment group showed significantly lower scores on validated measures of depression, anxiety, and irritability compared to placebo. The authors attributed the effects to lion's mane's capacity to support neuronal function and reduce neuroinflammation.

A 2023 randomized placebo-controlled trial in 41 healthy adults examined lion's mane over 28 days as well as its acute effects in a single-dose arm. The study found a trend toward reduced subjective stress in the 28-day group (p=0.051), falling just short of statistical significance. The same study found significant acute effects on cognitive processing speed. While the stress results did not reach conventional significance thresholds, the directional consistency with the 2010 Nagano trial across two distinct study populations adds weight to the mood hypothesis.

A randomized, double-blind, placebo-controlled study of 30 female subjects found that four weeks of Hericium erinaceus intake resulted in significantly reduced scores on measures of depression and anxiety compared to placebo. The study used validated psychometric instruments and delivered lion's mane through food rather than supplemental capsules. Nagano et al., Biomedical Research, 2010.

A double-blind, randomized, placebo-controlled trial of 41 healthy adults receiving standardized Hericium erinaceus for 28 days found a trend toward reduced subjective stress compared to placebo (p=0.051). The study also identified significant acute effects on cognitive processing speed in a single-dose arm. Docherty et al., Nutrients, 2023.

Neuroinflammation as a shared mechanism

The anti-neuroinflammatory properties of lion's mane provide the mechanistic link between its neuroprotective effects and its mood effects. Neuroinflammation is not confined to neurodegenerative disease — it operates along a spectrum, with mood disorders at one end and Alzheimer's disease at the other. The same pro-inflammatory cytokines that drive neuronal atrophy in Alzheimer's pathology also disrupt the serotonergic and noradrenergic systems that regulate mood.

Lion's mane polysaccharides suppress the NF-κB signaling pathway, reducing the release of TNF-α, IL-6, and other pro-inflammatory cytokines. This is the same anti-inflammatory mechanism documented in the neurodegeneration literature, now applied to the mood context. The implication is that lion's mane's benefits for anxiety and depression are not a separate pharmacological action — they are a downstream consequence of the same neuroinflammatory suppression that supports brain health more broadly.

A 2025 narrative review confirmed that Hericium erinaceus exerts anti-inflammatory activity through suppression of the NF-κB pathway and downregulation of pro-inflammatory cytokines including TNF-α and IL-6, mechanisms directly relevant to neuroinflammation-associated mood and cognitive disorders. Contato and Conte-Junior, Nutrients, 2025.

A systematic review of 26 studies confirmed anti-inflammatory and antioxidant effects of Hericium erinaceus across multiple biological systems, supporting its potential utility in conditions driven by chronic neuroinflammation, including mood disorders. Menon et al., Frontiers in Nutrition, 2025.

What the evidence does and does not show

The clinical evidence for lion's mane and mood is smaller in scale than for cognitive function. Two randomized controlled trials have found mood-related effects, but both used small sample sizes and relatively short follow-up periods. The 2010 Nagano trial used food-based delivery and studied a specific population (menopausal women). The 2023 Docherty study found a trend toward stress reduction that fell just short of statistical significance. Neither of these constitutes definitive clinical evidence for lion's mane as a mood intervention.

What the evidence does show is mechanistic plausibility backed by consistent directional signals across independent trials. The neurobiological case — NGF and BDNF support, neuroinflammatory suppression, NF-κB pathway modulation — is solid. The clinical signal, while not yet large-scale, points in the same direction as the mechanism predicts. This is the appropriate way to characterize the current state of the science: promising, mechanistically coherent, not yet definitive.

What this means for your plate

Lion's mane is not a substitute for evidence-based treatment of clinical anxiety or depression. Anyone experiencing significant mood symptoms should work with a qualified healthcare provider. What the existing evidence does support is the inclusion of lion's mane as part of a dietary pattern that promotes neurological health — one that targets the same biological mechanisms implicated in mood regulation through a whole-food route.

The 2010 Nagano trial delivered lion's mane through food, not capsules. That is the form in which the benefits were observed. Fresh lion's mane two to three times per week delivers the relevant bioactive compounds — hericenones, erinacines, beta-glucans, and anti-inflammatory polysaccharides — in the matrix studied by the research.

Continue exploring the Lion's Mane science

What Are the Proven Health Benefits of Lion's Mane Mushroom?
Can Lion's Mane Improve Memory and Focus? What the Clinical Trials Show
How Lion's Mane Stimulates Nerve Growth Factor — and Why That Matters
What Does the Research Say About Lion's Mane and Alzheimer's Disease?